1 |
Forner A, Lovet JM, Bruix J. Hepatocelluar carcinoma[J]. Lancet, 2012,379(9822):1245-1255.
|
2 |
|
3 |
Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials[J]. Radiology, 2002, 224(1): 47-54.
|
4 |
顾其胜, 奚延斐. 海藻酸与临床医学[M].上海: 第二军医大学出版社, 2006: 15-21.
|
5 |
|
6 |
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials[J]. BMJ,2011,343:d5928. doi: 10.1136/bmj.d5928.
|
7 |
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?[J]. Psychological Methods, 2006, 11(2): 193 -206.
|
8 |
Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test[J]. BMJ, 1997, 315(7109): 629-634.
|
9 |
|
10 |
|
11 |
|
12 |
张志国, 卢桂龙, 宋春青, 等. 海藻酸钠微球在中晚期原发性肝癌TACE治疗中的应用[J]. 西南国防医药, 2015, 25(10): 1089-1092.
|
13 |
黄秋峰, 李忱瑞, 许飞, 等. 明胶海绵颗粒与海藻酸钠微球经动脉化疗栓塞治疗原发性肝癌对比研究[J]. 中国介入影像与治疗学, 2016, 13(4): 195-199.
|
14 |
纪昌学, 冯晓波, 张勇, 等. 海藻酸钠微球在部分性脾栓塞术中的应用评价[J]. 临床放射学杂志, 2007, 26(1): 53-56.
|
15 |
Tajiri T, Onda M, Yoshida H, et al. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis[J]. Hepato-gastroenterology, 2001, 49(47): 1445-1448.
|
16 |
刘兆玉, 单明, 卢再鸣, 等. 海藻酸钠微球颗粒子宫动脉栓塞治疗子宫肌瘤的疗效分析[J]. 中国临床医学影像杂志, 2006, 17(1): 12-14.
|
17 |
Nitta N, Ohta S, Tanaka T, et al. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization[J]. European journal of radiology, 2008, 67(3): 536-540.
|
18 |
Paye F, Farges O, Dahmane M, et al. Cytolysis following chemoembolization for hepatocellular carcinoma[J]. Br J Surg, 1999, 86(2): 176-180.
|
19 |
盛晔, 祖庆泉, 刘圣, 等. 海藻酸钠微球栓塞治疗肝细胞癌患者的近期疗效[J/CD]. 中华介入放射学电子杂志, 2014,2(1): 3.
|
20 |
Eroğlu M, Kurşaklioğlu H, Misirli Y, et al. Chitosan-coated alginate microspheres for embolization and/or chemoembolization: in vivo studies[J]. J Microencapsul, 2006, 23(4): 367-376.
|